Skip to content

Prevalence of Fabry disease in patients with cerevrovascular disease.

Prevalence of Fabry disease in patients with cerevrovascular disease. - Prevalence of Fabry disease in patients with cerevrovascular disease.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000015160
Enrollment
200
Registered
2014-09-15
Start date
2014-06-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerevrovascular disease

Interventions

None listed

Sponsors

Yokohama Stroke and Brain Ccenter
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: None

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
serum alfa-GAL activity, serum Lyso-Gb3, gene

Countries

Japan

Contacts

Public ContactRyoko Imazeki

Yokohama Stroke and Brain Center Neurology

Kisaragi1967@aol.com045-753-2500

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026